Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 328

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression

Open access
Meijers, B. K. I., Evenepoel, P.·2011·Nephrology Dialysis Transplantation

Abstract

‘The special position assigned to urea appears to date from the time at which urea could not be formed synthetically and was believed to arise only in living matter. Now that urea is formed artificially, it has been robbed of much of its mystery.’ (A. R. Cushny, The secretion of urine, 1917) The fundamental insights into uraemic toxicity have evolved little since publication of the classical monograph by Cushny nearly a century ago [1]. Organic metabolites are still thought to substantially contribute to uremia (albeit urea might not be the culprit), yet evidence unequivocally demonstrating toxicity of any single uraemic constituent is lacking [2]. To advance research in uraemic toxicity, the European Toxin work group (EUTox) developed a classification of uraemic blood constituents according to characteristics that affect their removal during dialysis [3]. Besides small water-soluble molecules (e.g. urea and creatinine) and peptides/proteins (e.g. β2-microglobulin), they identified a group of solutes that circulate in equilibrium between free solute versus bound to carrier proteins. Tight protein binding severely limits solute clearances by dialysis [4]. Intriguingly, a substantial number of these so-called protein-bound uraemic retention solutes originate from protein fermentation in the large intestine, including p-cresyl sulfate and indoxyl sulfate [5]. Recently, several groups demonstrated direct associations between p-cresol, mainly reflecting p-cresyl sulfate, and overall mortality and cardiovascular disease in end-stage renal disease [6,7] and in chronic kidney disease (CKD) [8,9]. Likewise, direct associations between indoxyl sulfate and overall mortality and cardiovascular disease were reported [10]. While indoxyl sulfate and p-cresyl sulfate are frequently thought of as independent uraemic retention solutes, they share common ground. First, as mentioned before, p-cresyl sulfate and indoxyl sulfate both originate from bacterial protein fermentation in the large intestine. Colonic microbiota degrade tryptophan to indole. Further hydroxylation results in 3-hydroxy-indole, the majority of which is sulfonated to indoxyl sulfate. In parallel, fermentation of tyrosine results in p-cresol and ultimately p-cresyl sulfate [11]. Recently, we reported on sulfate conjugation of p-cresol in CKD [12,13]. Second, most p-cresyl sulfate and indoxyl sulfate circulates noncovalently bound to albumin and competes for the same albumin-binding sites (Sudlow site II) [14] (Figure 1). Indoxyl sulfate and p-cresyl sulfate are interchangeable marker molecules to study behaviour of protein-bound solutes during dialysis [15]. The colon is responsible for salvage of energy and possibly nitrogen from carbohydrate (CHO) and protein not digested in the upper gastrointestinal tract. Fermentation of the amino acids tyrosine and tryptophan by intestinal microbiota generates p-cresyl and indole, respectively. After absorption, these are further metabolized to generate p-cresyl sulfate and p-indoxyl sulfate. Indoxyl sulfate and p-cresyl sulfate circulate in equilibrium between a free solute fraction and a fraction bound to serum proteins. The best-characterized binding site is albumin Sudlow site II, for which indoxyl sulfate and p-cresyl sulfate are competitive binding inhibitors. In this issue of Nephrology Dialysis Transplantation, Wu et al. demonstrate that serum indoxyl sulfate is associated with progression of CKD, confirming previous findings. Niwa et al. first advanced the hypothesis that accumulation of indoxyl sulfate accelerates glomerular sclerosis and progression of kidney disease [16,17]. Animal and small-scale human studies on CKD patients suggested retardation of CKD progression by adsorption of indole in the large intestine [18,19]. Intriguingly, Wu et al. equally demonstrate that p-cresyl sulfate is associated with CKD progression. Does this indicate that indoxyl sulfate and p-cresyl sulfate be considered equally valid markers for CKD progression? This illustrates one of the key problems we are faced with when investigating uremia. One of the hallmarks of uraemic retention solutes is that they all move more or less in the same direction. When glomerular filtration rate falls, concentrations of the uraemic retention solutes we measure, and most likely a host of solutes that we are not aware of, all rise. Indeed, in the current study, Wu et al. observed a moderate correlation between indoxyl sulfate and estimated glomerular filtration rate (eGFR) (r −0.72, P < 0.001), between p-cresyl sulfate and eGFR (r −0.64, P < 0.001) and between indoxyl sulfate and p-cresyl sulfate (r 0.66, P < 0.001). From a statistical point of view, if nominally related measures actually quantify the same phenomenon, then they are redundant, i.e. collinear. This might lead us to conclude that indoxyl sulfate and p-cresyl sulfate are plain markers of kidney function. The strongpoint of the study by Wu et al. is that they went to great length to

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfq818

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 328

Metadata

Authors
Meijers, B. K. I., & Evenepoel, P.
Venue
Nephrology Dialysis Transplantation
Published
2011-02-22
Volume
26
Issue
3
Pages
759-761
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2002138274
Cited by
328
References
25
FWCI
6.36
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. https://app.cochat.ai/papers/10.1093/ndt/gfq818
The paper
Meijers, B. K. I., & Evenepoel, P. (2011). The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfq818

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.